Treatment with exosomes derived from PD-BM-MSC (PD-BM-MSC-derived exosome group) and PD therapy with l-Dopa (PD-l-Dopa group) enhanced the number of TH+ DAn compared to the PD group. Here, TH is linked to Parkinson disease.